The TGA gave low-dose cannabis sales without prescription the green light in February. But no product has jumped through all the regulatory hoops to market yet.
- Professor of Medicine and Chair of Clinical Pharmacology, University of Newcastle
It’s early days yet. But here’s what we know so far.
We’ve made a few mistakes in the past two years, when it comes to developing COVID drugs. Some were obvious and could have easily been avoided.
Contact Jennifer for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Newcastle, Australia
- Website
- X (formerly Twitter): @jenhelenmar
- Article Feed
- ORCID
- Joined
